Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1331/week)
Manufacturing
(590/week)
Energy
(428/week)
Technology
(1162/week)
Other Manufacturing
(416/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Autoimmunity
Jul 16, 2018
Scientific and Technology Breakthroughs Show Promise for Lupus and Other Immunologic Diseases
Jul 16, 2018
HSS Receives $5.6 Million Grant to Support Genomics Research to Prevent and Repair Tissue Damage
Jul 10, 2018
Major Lupus Stem Cell Study Receives Additional Funding from the National Institutes of Health
Jul 06, 2018
New Phadia 200 Advances In-vitro Diagnostics in Europe for Allergy and Autoimmune Conditions
Jun 27, 2018
Berlin Cures strengthens Business Advisory Board with the appointments of Ulf Berg, Ph.D., and Dragan Grabulovski, Ph.D.
Jun 26, 2018
Rigel Initiates Phase 1 Clinical Trial of R835, an IRAK1/4 Inhibitor for Autoimmune and Inflammatory Diseases
Jun 15, 2018
New Study Presented at the Annual European Congress of Rheumatology (EULAR 2018) Reveals Insights About Women with Chronic Rheumatic Diseases During Their Pregnancy Journey
Jun 07, 2018
DxTerity Announces Preliminary Results from the LIFT Study will be Presented at the 2018 Annual European Congress of Rheumatology
May 23, 2018
Berlin Cures Announces Formation of Scientific Advisory Board
May 16, 2018
Araim's Cibinetide in Inflammatory and Autoimmune Diseases: Increasing Evidence for Immune Modulation and Pleiotropic Benefit
May 09, 2018
Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders
May 08, 2018
Nektar Therapeutics Announces Initiation of a Phase 1b Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, in Patients with Systemic Lupus Erythematosus
Apr 26, 2018
Lupus Research Alliance and Lupus Therapeutics Collaborate with Bristol-Myers Squibb on a New Lupus Trial
Apr 26, 2018
New Data Supports Dalazatide from Kv1.3 Therapeutics as a Potential Therapy for Inclusion Body Myositis (IBM)
Apr 24, 2018
Autoimmune Disease and Metal Exposure: What You Need to Know
Apr 16, 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Apr 05, 2018
Feinstein Institute, NIH launch groundbreaking clinical trial for new lupus medication
Apr 03, 2018
Gliknik Announces Issuance of U.S. Patent for Use of Recombinant IVIG Mimetics
Apr 02, 2018
Prestigious Paul Ehrlich Award Bestowed Upon Araim Pharmaceuticals Founder, Anthony Cerami
Mar 26, 2018
Autoimmune Disease Diagnostics Market will accomplish moderate CAGR to exceed $16 Billion by 2024
‹‹
Page 6
››
Latest News
Aug 15, 2025
Exchange Income Corporation Announces August 2025 Dividend
Aug 15, 2025
NMG Provides Update on Advancement of its Phase-2 Projects and Market Conditions
Aug 15, 2025
Phase 3 Expansion of Singapore’s Changi Water Reclamation Plant set to commence
Aug 15, 2025
Peraton Deepens Its Commitment to Madison-Huntsville Region With Trash Pandas Sponsorship and Supply Drive
Aug 15, 2025
Ferla Launches the Royce Max – The Most Powerful Electric Cargo Bike Yet
Aug 15, 2025
Chemtrade Announces Strong Results for Q2 2025, Raises Guidance for 2025 to $475M - $500M; Implementing New...
Aug 15, 2025
Galaxy Closes $1.4 Billion Project Financing Facility to Accelerate Helios AI Datacenter Development
Aug 15, 2025
Red 6 Secures U.S. Air Force Contract to Revolutionize F-16 Pilot Training with World-First Augmented Reality...
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events